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ABSTRACT
Purpose: To evaluate the influence of minoxidil, a well known vasodilator, on ischemic flap necrosis prevention in rats.
Methods: Ventral cutaneous flaps, measuring 8x4cm, were designed in 20 Wistar rats based on the right cranial epigastric
artery. In the experiment group, 50 mg/kg/day of minoxidil sulfate was administered by orogastric tube and the same
amount of saline solution was administered to the control group. Such procedure was initiated 24h before surgery and kept
once a day through the 7th postoperative day. Microcirculation was evaluated with laser fluxometry 24h before surgical
procedure, at immediate postoperative and at the 7th postoperative day. Flap necrosis area was evaluated by 2 methods:
planimetry and weight/paper ratio. Results: A significant flow increase in distal and medial extremity at M1 (medial point 1)
(p=0,0484) was observed in the experiment group. There was significant difference in flap necrosis prevention in the
experiment group (p=0,0433), although after necrosis took place there was no significant difference in necrosis size.
(p=0,1051 and p=0,2799).Conclusion: Minoxidil sulfate is effective in avoiding necrosis in ischemic flaps, but after necrosis
is present there is no difference in survival area between experimental and control groups.
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RESUMO
Objetivos: Avaliar a influência do minoxidil, um vasodilatador, na prevenção de necrose, em retalhos isquêmicos, em ratos.
Métodos: Preparam-se retalhos cutâneos ventrais, medindo 8x4 cm, baseados na artéria epigástrica cranial direita, em 20
ratos - Wistar. Administrou-se 50 mg/kg/dia de sulfato de minoxidil aos ratos  do grupo experimento e o mesmo volume de
solução salina isotônica aos do grupo controle, por sonda oro-gástrica.  Iniciou-se o tratamento 24 horas antes da
operação e manteve-se, diariamente, por 7 dias, no pós-operatório. Realizou-se a avaliação da microcirculação dos retalhos
fluxometria a laser 24 horas antes da operação, no pós-operatório imediato e após 7 dias. Desenhou-se a área de necrose
do retalho em molde e avaliou-se em relação ao tamanho total por 2 métodos: planimetria e peso/papel. Resultados:
Constatou-se aumento de fluxo na extremidade distal e medial (M1) (p=0,0484), no grupo experimento. Houve diferença na
prevenção da necrose nos retalhos  do grupo experimento (p=0,0433), porém quando esta se instalou, não houve diferença
quanto ao tamanho da  área necrosada (p=0,1051 e p=0,2799). Conclusão:  O uso de minoxidil é efetivo para evitar a
instalação da necrose de retalhos potencialmente isquêmicos, porém, quando o processo se instala, não existe diferença
na sobrevida destes, com a dose e a via empregadas neste estudo, em ratos.
Descritores: Retalhos Cirúrgicos. Vasodilatadores. Minoxidil. Cicatrização de Feridas. Ratos.
Introduction
Cutaneous flap necrosis is a major complication due to
its irreversibility, which leads to partial or total loss of the
flap, and consequently undesirable results mainly in plastic
surgery. Multiple factors are involved in flap loss, and the
basic causes are venous congestion and arterial
insufficiency. Several mechanisms act in the process of
ischemia, vasoactive substances promoting vasospasm,
free radicals production, sodium - potassium pump
inactivation, endothelial cells edema, which lead to arterial
and venous thrombosis. Many methods have been used to
increase cutaneous flap viability. Besides surgical methods,
several pharmacological agents with different action
mechanisms have been used to increase flap survival.
According to Rohrich et al.1, to be effective a substance
must have the following characteristics: possible to be
evaluated clinically, easy administration, high therapeutic
action, reproducible results,  not expensive, known
mechanism of action, allow exclusive use in the post
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operative period, have established bioevaluation, and
prevent completely necrosis. These characteristics are not
encountered in a sole substance, and the lack of an effective
drug capable of ameliorating the survival of cutaneous flaps
is what stimulates the research and development of the
pharmaceutical companies. Minoxidil (3-óxido-2.4-diamino-
6-piperidinopyrimidine) is a strong peripheral vasodilator
drug (molecular weight 209,5). Its active substance (minoxidil
sulfate) causes dilatation of arterioles, but not of veins, by
opening the potassium channels. Minoxidil is also used for
the treatment of hypertension. Nowadays it is widely used
for the treatment of baldness because of its abilities as
cutaneous vasodilator and also by its availability for
administration per oral or topically. The cutaneous
vasodilation of minoxidil is associated with an increase in
blood flow to the potentially ischemic cutaneous flaps,
therefore augmenting its viability. Animal studies have
demonstrated that minoxidil is concentrated in the smooth
muscle of the aorta, femoral arteries and other great vessels
no matter the route by which it is administrated. It was also
observed that it activates the rennin-angiotensin system,
causing sodium and water retention. Despite the potential
benefits of minoxidil to increased the viability of cutaneous
flaps, Smith and Dolan did not show effective results with
the use of topic minoxidil 2% on the survival of dorsal skin
flaps in rats(10). Them aim of this study is to evaluate the
effect of oral minoxidil in the prevention of the necrosis of
ventral ischemic flaps in rats.
Methods
This study was approved by the Federal Law number
6.638 according to the orientations of the Brazilian College
of Animal Experimentation. The Project was approved by
the PUCPR Animal Care Ethics Committee. Twenty male
Wistar rats (Rattus norvegicus albinus, Rodentia
mammalia), 100 to 120 days old, weighing 250 to 350 g
(285,98g ± 24,20g ) from the PUCPR animal care department
were used in the experiment. The animals received standard
chow diet and tap water ad libitum during all the experiment.
The animals were randomized in 2 groups of 10 rats. The
study group received 50 mg/kg/day of oral minoxidil sulfate
by gavage, while the control group received a
correspondent amount of oral isotonic saline solution. The
treatment was initiated 24 hours before the operation and
continued until the 7th post-operative day. Rats were
anesthetized with intramuscular injections of a mixture of
ketamine (50mg/ml) and 1 ml of xylasine (0.2 ml/100g of
weight). Half of the initial dose was used as needed during
the procedure. In each animal, after tricotomy and assepsy
a 4x8 cutaneous flap was designed according to Petry and
Wortham(11) and modified by Biondo-Simões et al.(12) with a
special skin on the ventral abdominal wall. The medial limit
of the flap was the medial abdominal line and the inferior
limit was the superior edge of the pubis. The design of the
ventral abdominal wall cutaneous flap was performed, using
a mold previously prepared with 8 cm of length for 4 cm of
width, as described by Petry and modified by Biondo-
Simões. The medial limit of the mold was put on the midline
of the ventral abdominal wall, and the inferior limit of the
flap at the pubis.  After that the flap was drawn using the
mold.  Eight points were symmetrically distributed on the
flap: 1) The medial points: M1, M2, M3 and M4, which
started 1 cm from midline and 1 cm from inferior border of
the flap, and 1 cm apart from other point; and 2) The lateral
points, which where four points localized 1 cm from the
lateral limit of the flap and 1 cm from the inferior limit: L1, L2,
L3 and L4. Laser fluxometry was taken over these points.
(Figure 1).
FIGURE 1 - Aspects of the draw of the flap. Left: the
mold. Right: demarcation on the skin of
the rat and the points for blood flow
measurement.
An incision of the skin and subcutaneous tissue was
made on the medial, inferior and lateral lines of the previous
described draw. A flap of the fascia of the ventral abdominal
muscles was dissected out up to the identification of the
major division of the right caudal epigastric artery and its
lateral and medial branches, which were dissected and tied
up with mononylon 6.0. After its complete dissection, the
flap’s blood supply consisted only of the cranial epigastric
artery (Figure 2).
FIGURE 2 - Details of flap dissection. Right: inferior
epigastric artery. Left: superior epigastric
artery as pedicle.
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The flap was placed on the dissected area and fixed
with distribution points of mononylon 5.0. Ultimately the
synthesis of the remaining flap was performed, with
mononylon 6.0. The blood flow to the flap was analyzed 24
hours before the operation and before introducing the
medication by laser fluxometry (Laserflo BPM2
(Vasmedics®)), observing the 8 pre-described points, in
order to access the normal blood flow of each animal. This
method uses laser technology, which is able to analyze
aproximately 1.0 to 1.5 mm of the depth in the majority of
biological tissues. The analysis is performed by the
detection of the flow of red blood cells by ml of blood that
flows in a minute , divided by a 100 g of tissue (ml/min/
100g). Twenty four hours and seven days after the
procedure, the same 8 points were evaluated by laser
fluxometry. The fluxometer was suspended over each of the
pre-marked points on the abdominal region of the animal.
The evaluation of the necrosis area was performed by
measuring the necrotic area, dividing it by the flap area, and
multiplying it by 100; and the result is the percentage of
loss of the flap. The molds of the flap, and their corresponding
necrotic areas were scanned with a multifunction HP® R15
printer. The areas of the images were analyzed with the
program Paint® and Autocad® 2002. The Autocad program
produced standard scales, which allowed the verification
of results of the calculation of the areas. To verify the loss
of flap caused by necrosis, acetate molds of the same size
of the flap were used, which were previously weighed in an
electronic scale AS2000c, Marte®. The necrotic area was
removed and was not considered for the final analysis. The
remaining part of the mold was weighed and the percentage
of necrotic area of the flap was determined using proportion
studies. The statistical analysis was performed using the T-
Student test for the quantitative variables and independent
samples, or the non-parametric Mann-Whitney test, when
appropriated. The normal condition was verified by the
Shapiro-Wilks test. For the comparison of categorical
variables, the Fisher test was used. Significance was p<0.05.
Results
The mean weight of the control group was 291, 68 ±
26,12 g; and of the study group was 280,29 ± 21,96 g. The
samples were similar according to the t-student test
(p=0,3049). Despite the lack of a macroscopic evaluation of
the vessels, it was observed that the cranial epigastric artery
was vasodilated, mainly in the animals treated with Minoxidil
(Figura 3). Laser fluxometry showed an increased blood flow
on the lateral point (L3) (p=0.0374) and on the M1 point
(p=0.0484) on the 7o. post-operative day.  (Table 1). On the
1st post-operative day signs of decreased blood flow were
noticeable in some flaps, especially on their coloration,
which was violet on their distal part, mainly over M1 point.
The changes of color to black and blue were noticeable on
the 3o. and 7o. post-operative days, characterizing  necrosis.
The macroscopic signs of established necrosis were
observed on the 7o. post-operative day, in 10 flaps of the
control group and in 6 of the minoxidil group (p=0.0433).
The original flap consisted of an area of 32cm2. Analyzing
the scanned areas, it was possible to observe the necrotic
area and the percentage of necrotic area. There was no
significant statistical difference between the two groups
(p=0.1051) (Table 2). The evaluation of the necrotic area
was confirmed by the analysis of the weigh of the mold of
the necrotic flap. There was no significant difference
between the two groups. (p=0.2799) (Table 3).
FIGURE 3 - Superior epigastric artery caliber increase in
experiment group flap compared to control
group. Necrosis area at inferior and medial
portions of the flap.
TABLE 1 - Mean flow in every of eight points in three
different moments: preoperative, first
postoperative day and seventh postoperative
day (ml/min/100g)
     M Group      SF Group
N   Mean  DP n    Mean DP
L1_PRE 10 3.50 2.08 10 3.48 2.66 0.9705*
L1_1PO 10 2.65 1.64 8 1.59 1.47 0.1220*
L1_7PO 10 2.76 2.72 9 1.23 1.75 0.2775*
L2_PRE 9 6.19 2.80 8 6.87 2.53 0.6118
L2_1PO 10 2.91 1.97 10 1.91 1.27 0.1947
L2_7PO 9 3.47 2.69 10 3.37 2.07 0.9283
L3_PRE 8 5.14 2.10 10 5.18 1.38 0.9599
L3_1PO 9 4.61 2.52 10 3.09 1.08 0.0503
L3_7PO 10 7,06 4.51 9 3.43 1.82 0.0374
L4_PRE 10 5.099 2.32 10 5.01 2.79 0.2799*
L4_1PO 10 6.02 2.12 10 5.52 1.72 0.5699
L4_7PO 10 4.65 3.19 10 5.11 3.04 0.7438
M1_PRE 10 3.86 1.58 8 4.22 1.22 0.6093
M1_1PO 10 2.60 0.98 10 1.93 1.24 0.1957
M1_7PO 9 2.28 2.56 9 0.66 0.99 0.0484*
M2_PRE 10 5.82 2.31 10 6.07 1.98 0.7989
M2_1PO 10 3.46 1.08 10 2.67 1.09 0.0753*
M2_7PO 10 3.46 3.23 10 3.17 2.41 0.9118*
M3_PRE 10 8.00 3.20 10 6.28 1.37 0.1439
M3_1PO 10 4.79 1.36 10 4.48 1.22 0.2475*
M3_7PO 10 7.28 2.38 10 6.64 3.99 0.6686
M4_PRE 8 7.11 3.84 10 7.66 2.76 0.7292
M4_1PO 10 6.24 1.58 10 5.58 2.15 0.4388
M4_7PO 10 7.06 3.16 10 7.38 4.09 0.8465
(²) t de Student test
(*) Mann-Whitney test
OBS: artifacts readings have been excluded
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Discussion
It was observed only minimal changes between the 2
groups by the laser fluxometry analysis. On the 7th post-
operative day there was a significant increase in the blood
flow in the animals that received minoxidil, in the point M1
of the flap, the most distal and medial extremity of the flap,
and  in the point L3 (lateral and superior). However, this
method of evaluation, was not considered reliable, because
even over established necrotic areas it was observed the
presence of blood flow, possibly indicating that there were
reading artifacts, with the detection of blood vessels that
were under the flap. This study used planimetry and weight/
paper ratio methods to evaluate necrosis area, and it was
observed similar results in both methods. Therefore, any of
these two methods can be safely used. Smith and Dolan(10)
have first used minoxidil as a vasodilator substance to
prevent flap necrosis. They used topical minoxidil 2% in
ischemic flaps in rats; however the results were not effective.
The ineffectiveness of this substance by the topical
application motivated our study, which used the same
substance orally. Thomas et al.(7), have reported that
minoxidil was absorbed by the gastrointestinal tract in rats,
dogs and monkeys, and Pettinger(4) have described plasma
levels of this drug after 30 minutes of oral administration.
This study observed arterial dilation after oral minoxidil
administration. However, it is not possible to affirm that the
arterial dilation was caused only by the action of minoxidil,
because the arterial dilation was also observed
macroscopically in the control group, which received only
TABLE 2 - Necrosis area on the seventh postoperative day.
Control group (SF) Experiment Group (M)
Necrosis area (cm2) % Necrosis area (cm2) %
01 1.76 5.50 02 0.00 0.00
04 0.79 2.47 03 4.90 15.31
05 6.81 21.28 08 3.94 12.31
06 1.84 5.75 10 0.00 0.00
07 2.66 8.31 11 0.37 1.16
09 0.57 1.78 14 1.94 6.06
12 4.08 12.75 15 0.00 0.00
13 2.28 7.13 16 0.00 0.00
17 3.93 12.28 18 1.73 5.41
20 1.15 3.59 19 1.22 3.81
Mean 2.59 8.08 1.41 4.41
Maximum 6.81 21.28 4.90 15.31
Minimum 0.57 1.78 0.00 0.00
D.P. 190 5.94 1.76 5.51
Mann-Whitney test p=0,1051
TABLE 3 - Necrosis evaluation through weight ratio.
Control Group (SF) Experiment Group (M)
Necrosis area (g) % Necrosis area (g) %
01 0.03 4.84 02 0.00 0.00
04 0.01 1.61 03 0.10 16.13
05 0.15 24.19 08 0.10 16.13
06 0.04 6.45 10 0.00 0.00
07 0.03 4.84 11 0.04 6.45
09 0.03 4.84 14 0.04 6.45
12 0.10 16.13 15 0.00 0.00
13 0.07 11.29 16 0.00 0.00
17 0.08 12.90 18 0.06 9.68
20 0.01 1.61 19 0.01 1.61
Mean 0.055 8.87 0.035 5.64
Median 0.04 5.65 0.04 5.65
Maximum 0.15 24.19 0.10 16.13
Minimum 0.01 1.61 0.00 0.00
D.P. 0.0448 7.22 0.0403 6.51
Mann-Whitney test p=0,2799
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saline solution, therefore these results could be associated
with autonomization, as a response to ischemia. It has been
shown that 4 out of 10 flaps that were treated with minoxidil
didn’t show necrosis and this was statistically significant
(p<0.05). The survival area, analyzed by planimetry, showed
91.02% of survival for the control group and 95.59% for the
minoxidil group, however this difference was not statistically
significant. These results are possibly biased by the small
sample of animals. If we remove from the analysis the 4
flaps that didn’t present necrosis, it is observed that the
mean area of necrosis is 7.34, which is similar to that of the
control group (8,08%). Therefore, we believe that minoxidil
is effective for the prevention of the development of
necrosis, because 40% of the flaps of the animals treated
with minoxidil necrosis were prevented.  The route of the
administration of minoxidil, which was different from that
used by Smith and Dolan(10), was possibly the main factor
for the positive results seen in our study. We observed that
once necrosis developed, there is no significant difference
in length of necrosis between the study (minoxidil) and
control groups. Further studies are necessary, using
different flaps, routes of application and different doses, to
understand the effectiveness of minoxidil.
Conclusion
The use of minoxidil is effective to prevent the
establishment of necrosis in potentially ischemic flaps
in rats. However, when the ischemic process is present
there is no difference in flap survival area between
experimental and control groups, with the dose and route
used in this study.
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